Tony Rosenberg

Executive Partner at MPM Capital Inc

Tony Rosenberg

Tony Rosenberg

Executive Partner at MPM Capital Inc

Overview
RelSci Relationships

3955

Number of Boards

13

Birthday

1953

Age

68

Contact Data
Trying to get in touch with Tony Rosenberg? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Tony Rosenberg likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at MPM Capital Inc

Relationship likelihood: Strong

Chief Executive Officer at ProSiebenSat.1 Media SE

Relationship likelihood: Strong

Executive Partner at MPM Capital Inc

Relationship likelihood: Strong

Executive Partner at MPM Capital Inc

Relationship likelihood: Strong

President & Chief Executive Officer at eGenesis, Inc.

Relationship likelihood: Strong

Managing Director at MPM Asset Management LLC

Relationship likelihood: Strong

Former President & Head-Legal Affairs at Novartis Corporation

Relationship likelihood: Strong

Co-Founder at MPM Capital Inc

Relationship likelihood: Strong

Chief Executive Officer & Executive Director at argenx SE

Relationship likelihood: Strong

Chief Financial Officer & Principal Accounting Officer at argenx SE

Relationship likelihood: Strong

Paths to Tony Rosenberg
Potential Connections via
Relationship Science
You
Tony Rosenberg
Executive Partner at MPM Capital Inc
Education
BSc Biological Sciences

The University was founded as Leicester, Leicestershire and Rutland University College in 1921. The site for the University was donated by a local businessman, Thomas Fielding Johnson, in order to create a living memorial for all local people who made sacrifices during the First World War. This is reflected in the University's motto Ut vitam habeant – 'so that they may have life'. Students were first admitted to the college in 1921, sitting examinations for external degrees awarded of the University of London. In 1927 the institution became University College, Leicester; 30 years later the college was granted its Royal Charter. This gave it the status of a University with the right to award its own degrees.

Masters of Science Physiology

The University of London is a collegiate research university located in London, England, consisting of 18 constituent colleges, 10 research institutes and a number of central bodies. The nine largest institutions of the federal university, usually termed the colleges, are Birkbeck, Goldsmiths, King's College London, the London Business School, Queen Mary, Royal Holloway, SOAS, LSE and UCL. Formerly a constituent college, Imperial College London left the University of London in 2007.

Career History
Head-Business Development & Licensing
Prior - 2015

Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.

Executive Partner
2015 - ?

MPM invests in companies located in the US and across the globe. The firm focuses on companies that aim to revolutionize the face of medicine across multiple areas including cancer, diabetes, obesity, pain, eHealth and health technology sector. They provide financing for early stage transactions.

Brand Manager
Tenure Unconfirmed

Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.

Boards & Committees
Non-Executive Chairman
2018 - Current

Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland.

Chairman
2017 - Current

Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.

Chairman, Board of Directors
2017 - Current

Cullinan Oncology, Inc. is a biopharmaceutical company engages in developing oncology and immuno-oncology therapies. The company was founded by Patrick R. Baeuerle on 15 September, 2016 and is headquartered in Cambridge, MA.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Tony Rosenberg. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Tony Rosenberg's profile does not indicate a business or promotional relationship of any kind between RelSci and Tony Rosenberg.